L

Lunit Inc
KOSDAQ:328130

Watchlist Manager
Lunit Inc
KOSDAQ:328130
Watchlist
Price: 39 250 KRW 0.13% Market Closed
Market Cap: 1.1T KRW

Lunit Inc
Other Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Lunit Inc
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
L
Lunit Inc
KOSDAQ:328130
Other Current Liabilities
₩8.5B
CAGR 3-Years
-54%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
I
Infinitt Healthcare Co Ltd
KOSDAQ:071200
Other Current Liabilities
₩31.3B
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
14%
U
UBCare Co Ltd
KOSDAQ:032620
Other Current Liabilities
₩14.7B
CAGR 3-Years
17%
CAGR 5-Years
11%
CAGR 10-Years
12%
L
LifeSemantics Corp
KOSDAQ:347700
Other Current Liabilities
₩9.4B
CAGR 3-Years
109%
CAGR 5-Years
40%
CAGR 10-Years
N/A
e
ezCaretech Co Ltd
KOSDAQ:099750
Other Current Liabilities
₩5.3B
CAGR 3-Years
-17%
CAGR 5-Years
6%
CAGR 10-Years
N/A
C
CJ Bioscience Inc
KOSDAQ:311690
Other Current Liabilities
₩3.7B
CAGR 3-Years
13%
CAGR 5-Years
22%
CAGR 10-Years
N/A
No Stocks Found

Lunit Inc
Glance View

Market Cap
1.1T KRW
Industry
Health Care

Lunit Inc., founded in South Korea, stands as a pioneering force in the application of artificial intelligence within the realm of medical technology. As a company at the intersection of healthcare and cutting-edge AI, Lunit crafts advanced solutions that enhance the diagnostic processes in radiology and oncology. The company's name, derived from "learning unit," underscores its mission to employ deep learning as a core component in transforming medical diagnostics. At the heart of Lunit’s operations are their flagship products, Lunit INSIGHT and Lunit SCOPE, which are designed to empower physicians by providing highly accurate diagnostic readings and treatment predictions. With this technology, Lunit aims to reduce diagnostic errors and improve the efficiency of medical imaging analysis, ultimately enhancing patient treatment outcomes. Lunit generates revenue through strategic partnerships and sales of their AI software solutions to hospitals and healthcare providers globally. The company's business model involves not only licensing its AI technologies but also integrating them with existing medical imaging equipment, thus enhancing the value derived from traditional diagnostic tools. By collaborating with prominent medical device manufacturers and healthcare institutions, Lunit ensures both the scalability and adaptability of its products in diverse clinical settings. Additionally, they actively engage in research collaborations and pilot programs to further their technological advancements and expand their market presence. Through these endeavors, Lunit is steadily carving out a crucial role in the healthcare sector by offering AI-driven solutions that promise to revolutionize patient care.

Lunit Inc Intrinsic Value
HIDDEN
Show

See Also

What is Lunit Inc's Other Current Liabilities?
Other Current Liabilities
8.5B KRW

Based on the financial report for Dec 31, 2024, Lunit Inc's Other Current Liabilities amounts to 8.5B KRW.

What is Lunit Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-38%

Over the last year, the Other Current Liabilities growth was 0%. The average annual Other Current Liabilities growth rates for Lunit Inc have been -54% over the past three years , -38% over the past five years .

Back to Top